Cannabis use disorder

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17

Cannabis diagnosis was the most prevalent substance use disorder across all age, sex, racial/ethnic, and treatment setting groups among youth psychiatric patients, accounting for more than 80% of all

Effect: decline; Cannabis SUD 10.4% of all patients; >80% of all SUD cases; 21.2% among ages 13-17